xnx: The Effect of Aerobic Exercise on Genetic Molecules

Sponsor
Pamukkale University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04181853
Collaborator
(none)
90
2
3
22.8
45
2

Study Details

Study Description

Brief Summary

The aim of this study is to compare the effects of high intensity interval exercise and moderate intensity continuous exercise on some genetic molecules in patients with type 2 diabetes mellitus.

Condition or Disease Intervention/Treatment Phase
  • Other: exercise
N/A

Detailed Description

Volunteers with type 2 diabetes mellitus will be evaluated in terms of any contra-indication that will restrain them from making exercise. 90 male or female volunteers who are suitable in terms of inclusion/exclusion criteria will be invited for the study. Volunteers will be randomly distributed to one of the 3 groups. Each group will contain 30 participants. 1. group will make aerobic exercise which is in the form of high intensity interval exercise 2.group will make aerobic exercise which is in the form of moderate intensity continuous exercise 3. Control group. Exercise groups will be cycling under observation in the hospital setting. Control group will make simple stretching exercises at home. Participants will be requested to complete a 3 months of exercise. They will be evaluated before and at the end of the 3 months of exercise with blood tests to measure genetic molecules related with metabolism.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The study has 3 armsThe study has 3 arms
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
Participants wil be making exercise. It is not possible to make participants blinded to the study.
Primary Purpose:
Supportive Care
Official Title:
The Effect of Aerobic Exercise on Genetic Molecules Related With Metabolism
Actual Study Start Date :
Feb 5, 2020
Anticipated Primary Completion Date :
Dec 30, 2021
Anticipated Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: High intensity interval exercise

Participants with type 2 Diabetes mellitus in High intensity interval exercise (HIIE) group will make aerobic exercise using bicycle at high intensity followed by low intensity periods under observation in the hospital.

Other: exercise
aerobic exercise

Active Comparator: Moderate intensity continuous exercise

Participants with type 2 Diabetes mellitus in Moderate intensity continuous exercise (MIC) group will make aerobic exercise using bicycle at moderate intensity during the session under observation in the hospital.

Other: exercise
aerobic exercise

No Intervention: No Intervention: Control group

Participants with type 2 Diabetes mellitus in Moderate intensity continuous exercise (MIC) group will make aerobic exercise using bicycle at moderate intensity during the session under observation in the hospital.

Outcome Measures

Primary Outcome Measures

  1. genetic molecules [12 weeks]

    HbA1c level in the serum

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 74 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Clinica diagnosis of type 2 Diabetes mellitus less than 10 years and more than 1 year.

  • must have appropriate medical therapy and diet.

  • must not be treated with insulin.

  • must be exercising less than 210 minutes/ week

Exclusion Criteria:
  • prominent cardiovascular disease

  • coronary artery disease

  • moderate to severe valvular disease

  • atrial fibrillation

  • untreated hypertension

  • congenital heart disease

  • retinopathy

  • neuropathy

  • macro albuminuria

  • cerebrovascular disease

  • ejection fraction less than 40

  • body mass index greater than 35.

  • prominent ischemic changes in EKG at rest or during exercise.

  • cigarette or alcohol addiction

  • on drugs that interferes with body fat distribution (such as insulin, thiazolidinediones

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pamukkale University Denizli Turkey 20100
2 Pamukkale University Denizli Turkey 21600

Sponsors and Collaborators

  • Pamukkale University

Investigators

  • Principal Investigator: Gulin Findikoglu, Assoc Prof, Pamukkale University,Medical Faculty, PMR Department

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
GULIN FINDIKOGLU, Associate Professor, Pamukkale University
ClinicalTrials.gov Identifier:
NCT04181853
Other Study ID Numbers:
  • 60116787-020/83243
First Posted:
Dec 2, 2019
Last Update Posted:
Dec 16, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by GULIN FINDIKOGLU, Associate Professor, Pamukkale University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 16, 2020